Clinical Trials Logo

Clinical Trial Summary

The aim of our study is to determine the range of frontal horn sizes (both upside and downside) in healthy fetuses over gestation and to determine how far FHs are from the midline . Also to determine the range of cavum septi pellucidi and Corpus callosum sizes . Also, to determine whether the maternal body mass index (BMI) affects rates of visualized and non-visualized CSP and CC.


Clinical Trial Description

Fetal central nervous system (CNS) abnormalities are among the most commonly encountered congenital abnormalities . Many different methods can be used to obtain prenatal diagnoses, including ultrasound (US), which is one of the most commonly used methods .Neonatal survival rates have increased over the last decades leading to increased number of infants with adverse neurodevelopmental outcomes, including cognitive, motor impairments and behavioral and learning difficulties later in life . Recent studies demonstrated that signs of abnormal neurological development are already present at birth . Frontal horns (FHs) are the most anterior portions of the lateral ventricles, on each side the cavum septi pellucidi (CSP). In accordance with practice parameters released as early as 1985 by the American Institute of Ultrasound in Medicine, American College of Obstetrics and Gynecology, and Society of Radiologists in Ultrasound, the CSP is examined in screening fetal ultrasound (US) examinations in the biparietal diameter view . Frontal horns (FH) are also visualized in the same plane. Abnormal morphologic characteristics of the FHs such as enlargement, squaring, spearing, and splaying may have an association with congenital intracranial anomalies such as holoprosencephaly, schizencephaly and agenesis of the corpus callosum . The corpus callosum (CC) is the largest interhemispheric white matter commissure of the human brain . It is a sensitive indicator of normal brain development and maturation ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06410391
Study type Observational
Source Assiut University
Contact Mohamed Fekry, PhD
Phone 0882312388
Email mohamedbeethoven2040@gmail.com
Status Recruiting
Phase
Start date June 15, 2024
Completion date November 2024

See also
  Status Clinical Trial Phase
Completed NCT02965287 - Validation of a Test for Fetal Malformations
Completed NCT05527327 - Pannus Retraction for Ultrasound Evaluation of the Obese Gravida: A Pilot Study N/A
Completed NCT05655741 - Modified Delphi for Genomic Bereavement Care
Enrolling by invitation NCT03412760 - Hydrops: Diagnosing & Redefining Outcomes With Precision Study N/A
Recruiting NCT05790473 - Artificial Intelligence Algorithm for the Screening of Abnormal Fetal Brain Findings at First Trimester Ultrasound Scan
Recruiting NCT03398629 - Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies
Completed NCT05764408 - Pannus Assistance Needed for Obstetric Ultrasound Studies N/A
Not yet recruiting NCT04897178 - Machine Learning-based Anomaly Recognition System
Completed NCT02664207 - Extended Criteria For Fetal Myelomeningocele Repair N/A
Completed NCT02875860 - 'TOTAL' (Tracheal Occlusion To Accelerate Lung Growth) Trial Phase 2
Completed NCT05785338 - Trial Observationnal
Completed NCT03795857 - Antenatal Palliative Care
Completed NCT04174235 - Prevalence of Fetal Congenital Anomalies Among Pregnant Women Attending University Hospital
Completed NCT03544970 - An Audit of the Posterior Fossa Characterization in Open Spina Bifida Based on Tertiary Center Experience